Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDB

MongoDB Inc

439.16

Aug 11 • 3:59 PM ET +22.49 (5.40%)

438.84

Aftermarket • 7:59 PM ET -0.32 (-0.07%)

Technology Software - Infrastructure USA Large NASD

Peers: NET SNOW DDOG NBIS PLTR NOW AI WDAY CRM BBAI

| Held by: VTI VO VUG VXF VGT VOT IWP IWR IWF SKYY

Index	-
Market Cap	35.32B
Enterprise Value	32.95B
Income	-29.09M
Sales	2.60B
Book/sh	36.46
Cash/sh	30.18
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	5636
IPO	Oct 19, 2017

P/E	-
Forward P/E	60.01
PEG	2.67
P/S	13.57
P/B	12.05
P/C	14.55
P/FCF	59.75
EV/EBITDA	-
EV/Sales	12.66
Quick Ratio	4.74
Current Ratio	4.74
Debt/Eq	0.02
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-0.37
EPS next Y	7.32
EPS next Q	1.61
EPS this Y	23.06%
EPS next Y	19.65%
EPS next 5Y	22.45%
EPS past 3/5Y	44.17% 28.00%
Sales past 3/5Y	24.26% 33.07%
EPS Y/Y TTM	68.36%
Sales Y/Y TTM	23.64%
EPS Q/Q	111.72%
Sales Q/Q	25.25%
Earnings	Sep 01 AMC
EPS/Sales Surpr.	10.80% 3.47%

Insider Own	3.95%
Insider Trans	-5.69%
Inst Own	93.25%
Inst Trans	-1.27%
ROA	-0.80%
ROE	-0.97%
ROIC	-0.98%
Gross Margin	71.67%
Oper. Margin	-4.18%
Profit Margin	-1.12%
SMA20	28.20%
SMA50	27.17%
SMA200	30.76%
Trades

Shs Outstand	80.50M
Shs Float	77.26M
Short Float	3.36%
Short Ratio	1.30
Short Interest	2.60M
52W High	444.72 -1.25%
52W Low	198.47 121.27%
Volatility	5.54% 5.82%
ATR (14)	20.88
RSI (14)	76.56
Beta	1.58
Rel Volume	0.89
Avg Volume	1.99M
Volume	1,767,025

Perf Week	15.56%
Perf Month	29.94%
Perf Quarter	49.04%
Perf Half Y	22.75%
Perf YTD	4.64%
Perf Year	118.49%
Perf 3Y	23.28%
Perf 5Y	21.67%
Perf 10Y	-
Recom	1.59
Target Price	408.15
Prev Close	416.67
Price	439.16
Change %	5.40%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-26	Reiterated	Needham	Buy	$400 → $430
May-29-26	Reiterated	Monness Crespi & Hardt	Buy	$370 → $415
May-15-26	Reiterated	BMO Capital Markets	Outperform	$285 → $360
Mar-23-26	Upgrade	Mizuho	Neutral → Outperform	$325
Mar-05-26	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$310
Mar-03-26	Reiterated	Monness Crespi & Hardt	Buy	$475 → $370
Mar-03-26	Reiterated	BMO Capital Markets	Outperform	$400 → $340
Mar-03-26	Downgrade	Robert W. Baird	Outperform → Neutral	$260
Feb-26-26	Reiterated	BMO Capital Markets	Outperform	$455 → $400
Jan-06-26	Reiterated	Needham	Buy	$480 → $500
Dec-16-25	Initiated	Raymond James	Mkt Perform
Dec-02-25	Reiterated	Monness Crespi & Hardt	Buy	$360 → $475
Dec-02-25	Reiterated	BMO Capital Markets	Outperform	$415 → $455
Nov-18-25	Initiated	Guggenheim	Neutral	$400
Oct-01-25	Initiated	Wells Fargo	Overweight	$430
Sep-18-25	Reiterated	BMO Capital Markets	Outperform	$315 → $365
Aug-27-25	Reiterated	Monness Crespi & Hardt	Buy	$295 → $360
Aug-27-25	Reiterated	BMO Capital Markets	Outperform	$280 → $315
Jul-28-25	Initiated	BMO Capital Markets	Outperform	$280
Jul-18-25	Initiated	Stephens	Equal-Weight	$247

Show Previous Ratings

Aug-11-26 06:53AM	Citi bullish on MongoDB stock, expects significant positive estimate revisions (Investing.com) +5.40%
Aug-05-26 11:43AM	Avatar Robotics Raises $6.5 Million Seed to Build the Unlimited Industrial Workforce (PR Newswire)
Aug-04-26 02:39PM	MongoDB, Inc. Announces Date of Second Quarter Fiscal 2027 Earnings Call (PR Newswire) +6.17%
Jul-08-26 07:27AM	Own ServiceNow For AI? Gen Digital's Numbers Speak Louder (Trefis)
Jul-07-26 08:10AM	GEN Grew. The Stock Did Not. Someone Is Wrong (Trefis)
12:50PM	Loading…
Jul-03-26 12:50PM	Did MongoDB, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Jun-30-26 12:30AM	MongoDB Delivers Accurate AI Retrieval Wherever Enterprise Data Lives (PR Newswire)
Jun-17-26 04:03PM	PayPal mafia member and exSequoia steward Roelof Botha joins SpaceX boardreuniting with Elon Musk after decades (Fortune)
Jun-10-26 11:54AM	Infrastructure Software Stocks Look Strong. Snowflake Among Analyst's 'Fab Five' To Watch. (Investor's Business Daily)
Jun-05-26 03:54PM	Did MongoDB, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire) -7.74%
Jun-03-26 05:32AM	The 'Lifeboat Effect': Money Moving From Seat To Stack (Stocktwits) -7.56%
Jun-02-26 09:41AM	Why The AI Agentic Era Doesn't Justify A Premium For MongoDB Stock Just Yet (Trefis)
Jun-01-26 11:20AM	MongoDB, Inc. to Present at Upcoming Investor Conferences (PR Newswire) +20.36%
May-29-26 10:27AM	MongoDB tops Q1 estimates, raises full-year outlook on Atlas strength (Proactive)
10:23AM	MongoDB climbs after first-quarter beat and stronger full-year guidance (MDB) (InvestorsHub)
09:21AM	Loading…
09:21AM	MongoDB Stock Rallies After Earnings. Investors Are Debating When It Lands In 'AI Winner Circle.' (Investor's Business Daily)
08:20AM	MongoDB's Atlas Streak Powers Beat and Full-Year Guidance Raise (GuruFocus.com)
08:08AM	Data layer emerges as the defining battleground of the AI revolution (Proactive)
04:53AM	MongoDB Stock Rises on Earnings Beat. Software Isn't Dead Yet. (Barrons.com)
01:00AM	MongoDB Inc (MDB) Q1 2027 Earnings Call Highlights: Strong Revenue Growth and Expanding ... (GuruFocus.com)
May-28-26 10:40PM	Why MDB Stock Is Up Overnight After Wild Ride Today (Stocktwits) +10.60%
04:48PM	MongoDB raises guide on AI demand; stock pares after-hours gains on call (Investing.com)
04:19PM	MongoDB: Fiscal Q1 Earnings Snapshot (Associated Press)
04:05PM	MongoDB, Inc. Announces First Quarter Fiscal 2027 Financial Results (PR Newswire)
09:41AM	Microns Cheap Stock Valuation Seen as a Contrarian Warning Sign (Bloomberg)
04:33AM	Dell earnings arrive following stock's surge (MarketWatch)
03:33AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to fall as oil rises after U.S. and Iran strike one another; PCE inflation on tap (MarketWatch)
May-26-26 03:59PM	MongoDB Q1 preview: Wedbush sees upside to street estimates on Atlas growth, AI momentum (Proactive) -5.76%
May-21-26 01:00PM	The Week Ahead: Retail Earnings, PCE Inflation Data (Schaeffer's Research)
May-19-26 03:35PM	MongoDB price target lifted by Bank of America ahead of earnings (Proactive)
07:06AM	Loading…
May-12-26 07:06AM	MongoDB rises as Citi opens positive catalyst watch on stock, lifts target price (Investing.com)
May-07-26 04:56PM	Software Shines With Booming Earnings Season Thundering Along (The Wall Street Journal) +10.62%
10:42AM	MongoDB 8.3 Is Out and Shares Are Up 10% (GuruFocus.com)
04:00AM	MongoDB Makes Enterprise AI Production Ready (PR Newswire)
May-05-26 02:20PM	Did MongoDB, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Apr-23-26 04:00AM	MongoDB Announces 74M Ireland Expansion, 200 Jobs, and New Cork Office (PR Newswire)
Apr-22-26 09:00AM	MongoDB Expands Product Leadership to Accelerate Growth and Innovation (PR Newswire)
Apr-09-26 08:02PM	Bear Of The Day: MongoDB (MDB) (Quartz) -8.32%
Mar-24-26 08:50AM	MongoDB Appoints Ryan Mac Ban as Chief Revenue Officer to Support Next Phase of Growth (PR Newswire) -7.13%
Mar-23-26 09:44AM	Super Micro downgraded, MongoDB upgraded: Wall Street's top analyst calls (The Fly)
09:30AM	Mizuho upgrades MongoDB on AI-driven demand and stronger customer growth (Investing.com)
Mar-13-26 03:01PM	Software sector sees C-suite shake-ups amid AI disruption fears (CNBC TV)
Mar-09-26 10:26AM	Oracle's AI Push: A Potential Catalyst for Q3 Earnings Growth? (Zacks)
Mar-08-26 11:00AM	Celsius, Carnival Corp., MongoDB Are Among Top 10 Large Cap Losers Last Week (March 2-March 6): Are the Others in Your Portfolio? (Benzinga)
Mar-06-26 09:13AM	Should You Buy, Sell or Hold MongoDB Stock Post Q4 Earnings? (Zacks)
Mar-05-26 11:51AM	Why MongoDB (MDB) Stock Is Trading Up Today (StockStory) +6.42%
10:31AM	MongoDB Expands AI Capabilities: Is the Growth Thesis Strengthening? (Zacks)
09:36AM	Meta downgraded, MongoDB upgraded: Wall Street's top analyst calls (The Fly)
08:30AM	MongoDB, Inc. Q4 2026 Earnings Call Summary (Moby)
08:01AM	Here Are Thursdays Top Wall Street Analyst Research Calls: Astera Labs, Block, CoreWeave, Digital Realty, Mastercard, Meta Platforms, MongoDB, StubHub, and More (24/7 Wall St.)
Mar-04-26 09:03AM	MongoDB Q4 Earnings & Revenues Surpass Estimates, Both Increase Y/Y (Zacks)
07:34AM	MongoDB (MDB) Rose by Overall Positive Sentiment (Insider Monkey)
07:19AM	GitLab Stock Tumbles Again. Why the Software Pain Isn't Over. (Barrons.com)
Mar-03-26 06:35PM	Software stocks just quietly trounced chip stocks to a historic extent - but don't get too excited (MarketWatch) -22.24%
05:40PM	MongoDB Tumbles as Weak Forecast Revives Concerns (Bloomberg)
05:19PM	Stocks to Watch Tuesday Recap: Target, Best Buy, Pinterest, MongoDB (The Wall Street Journal)
04:39PM	Stocks Settle Lower on Iran War Anxiety (Barchart)
04:39PM	These Stocks Are Todays Movers: MongoDB, Archer Aviation, Target, Blackstone, Quantum Computing, Plug Power, and More (Barrons.com)
04:28PM	Stock Market Today: Dow Loses 400 Points Amid U.S.-Iran Battle; Palantir Climbs As Nvidia Slips (Live Coverage) (Investor's Business Daily)
04:15PM	MongoDB Stock Just Entered Oversold Territory. Should You Buy the Dip in MDB? (Barchart)
04:05PM	MongoDB, Inc. to Present at the Morgan Stanley Technology, Media & Telecom Conference (PR Newswire)
03:23PM	Iran War Escalation, Oil Spike Rattle Wall Street: What's Moving Markets Tuesday? (Benzinga)
03:22PM	Stock Market Today: Dow Trims Losses Amid U.S.-Iran Fighting; Palantir Rises (Live Coverage) (Investor's Business Daily)
03:00PM	Stock Market Today: Dow Cuts Losses Over U.S.-Iran; These Oil Firms Move Up (Live Coverage) (Investor's Business Daily)
02:57PM	Why Is the US Stock Market Down Today? (BeInCrypto)
02:50PM	MongoDB Slips Into a Super-Mongo Buying Opportunity (MarketBeat)
02:35PM	What's Going On With MongoDB Stock Today? (Benzinga)
01:33PM	Stock Market Today: Dow Slides 400 Points On U.S.-Iran Combat; These Oil Companies Move Up (Live Coverage) (Investor's Business Daily)
01:30PM	MongoDB's 25% Drop Sparks Debate (GuruFocus.com)
01:05PM	Why MongoDB (MDB) Shares Are Falling Today (StockStory)
12:43PM	MongoDB Stock Tumbles 21%. Why Analysts Still Say Buy. (Barrons.com)
11:45AM	MongoDB shares plummet 27% on weak growth in cloud business, muted forecast (Reuters)
11:29AM	Blackstone stock at 2023 low, MongoDB stock nosedives on earnings (Yahoo Finance Video)
11:11AM	MongoDB Guides 21%-23% Atlas Growth After 27% Revenue Jump (GuruFocus.com)
10:02AM	MongoDB Stock Down Over 25% After Guidance Whiff (Schaeffer's Research)
09:51AM	Stock Market Today: Dow Dives 900 Points On U.S.-Iran Fears; Nvidia Sells Off (Live Coverage) (Investor's Business Daily)
09:43AM	Stocks to Watch Tuesday: Target, Best Buy, Pinterest, MongoDB (The Wall Street Journal)
09:33AM	MongoDB downgraded, Block upgraded: Wall Street's top analyst calls (The Fly)
09:01AM	Why MongoDB Stock Is Tumbling Despite A Q4 Earnings Beat (Investor's Business Daily)
08:32AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:19AM	MRVL Q4 Earnings to Gain From Custom AI & Connectivity Products (Zacks)
08:12AM	Stock Market Today: Dow Dives 700 Points On U.S.-Iran Fears; Credo, MongoDB Fall On Results (Live Coverage) (Investor's Business Daily)
08:00AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More (24/7 Wall St.)
06:55AM	MongoDB shares slide as software woes continue, and other early market movers (MarketWatch)
06:16AM	MongoDB Stock Sinks 20% on Weak Profit Forecast (GuruFocus.com)
06:09AM	These Stocks Are Today's Movers: MongoDB, Archer Aviation, Plug Power, AST SpaceMobile, Quantum Computing, Micron, Cheniere, and More (Barrons.com)
05:27AM	MongoDB Stock Falls 27% Even as Earnings Beat Estimates (Barrons.com)
05:05AM	Appian CFO: AI Boosts Win Rates as Enterprises Automate Mission-Critical Workflows at TMT Conference (MarketBeat)
12:00AM	MongoDB Inc (MDB) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Record Deals ... (GuruFocus.com)
Mar-02-26 09:23PM	MongoDB's stock sinks after earnings, signaling more tough times for the software sector (MarketWatch)
08:54PM	Dow Jones Futures Fall: U.S.-Iran Conflict Sparks Market Upheaval As Nvidia Rallies; Credo, MongoDB Plunge Late (Investor's Business Daily)
08:46PM	Berkshire Hathaway, AST SpaceMobile, MongoDB, Credo Technology And BigBear.AI: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
07:27PM	MongoDB Q4 Earnings Call Highlights (MarketBeat)
06:00PM	MongoDB (MDB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	MongoDB (MDB) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
05:05PM	MongoDB Stock Falls Over 20%, Even After Earnings Beat (Barrons.com)
04:38PM	Earnings live: MongoDB stock tumbles, Norwegian Cruise Line sinks, with Target earnings on deck (Yahoo Finance)
04:34PM	MongoDB Stock Crashes After Q4 Earnings: Here's Why (Benzinga)
04:34PM	MongoDB (NASDAQ:MDB) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops 23.5% (StockStory)
04:28PM	MongoDB: Fiscal Q4 Earnings Snapshot (Associated Press Finance)

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

PresidentMr. Chirantan Jitendra Desai

Co-Founder & DirectorMr. Dwight A. Merriman

CFO & Principal Financial OfficerMr. Michael J. Berry

Chief Accounting Officer & Principal Accounting OfficerMr. Kong Phan

Chief Technology OfficerMr. Jim Scharf

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MERRIMAN DWIGHT A	Director	Jul 14 '26	Sale	320.31	10,000	3,203,118	972,953	Jul 16 04:39 PM
MERRIMAN DWIGHT A	Director	Jul 16 '26	Sale	329.56	6,000	1,977,349	458,896	Jul 16 04:39 PM
MERRIMAN DWIGHT A	Director	Jul 16 '26	Proposed Sale	329.43	6,000	1,976,557		Jul 16 01:24 PM
MERRIMAN DWIGHT A	Director	Jul 14 '26	Proposed Sale	320.18	10,000	3,201,794		Jul 14 10:37 AM
Cochran Hope F	Director	Jul 01 '26	Sale	350.00	1,000	350,000	29,326	Jul 02 04:49 PM
MERRIMAN DWIGHT A	Director	Jun 30 '26	Sale	334.25	1,130	377,702	982,953	Jul 02 04:46 PM
HOPE COCHRAN	Director	Jul 01 '26	Proposed Sale	335.90	2,000	671,800		Jul 01 04:18 PM
MERRIMAN DWIGHT A	Director	Jun 30 '26	Proposed Sale	334.02	1,130	377,438		Jun 30 12:59 PM
Cochran Hope F	Director	Jun 17 '26	Option Exercise	7.58	3,916	29,683	29,360	Jun 22 04:32 PM
Cochran Hope F	Director	Jun 17 '26	Sale	344.05	1,566	538,782	25,444	Jun 22 04:32 PM
BERRY MICHAEL J	Chief Financial Officer	Jun 16 '26	Sale	351.11	5,000	1,755,537	1,500	Jun 18 04:36 PM
HOPE COCHRAN	Director	Jun 17 '26	Proposed Sale	348.81	1,000	348,810		Jun 17 04:31 PM
BERRY MICHAEL J	Chief Financial Officer	Jun 15 '26	Sale	356.63	5,000	1,783,140	6,500	Jun 17 04:25 PM
MERRIMAN DWIGHT A	Director	Jun 12 '26	Sale	353.91	10,000	3,539,112	983,316	Jun 16 04:37 PM
MERRIMAN DWIGHT A	Director	Jun 15 '26	Sale	348.92	6,000	2,093,520	464,896	Jun 16 04:37 PM
Michael J. Berry	Officer	Jun 15 '26	Proposed Sale	342.80	10,000	3,428,000		Jun 15 04:25 PM
MERRIMAN DWIGHT A	Director	Jun 15 '26	Proposed Sale	348.79	6,000	2,092,731		Jun 15 11:22 AM
MERRIMAN DWIGHT A	Director	Jun 12 '26	Proposed Sale	353.78	10,000	3,537,781		Jun 12 11:32 AM
Ittycheria Dev	Director	Jun 04 '26	Sale	383.16	40,000	15,326,487	161,762	Jun 08 04:20 PM
BOTHA ROELOF	Director	Jun 02 '26	Sale	398.07	44,050	17,534,803	150,550	Jun 04 04:27 PM
Dev Ittycheria	Director	Jun 04 '26	Proposed Sale	383.16	40,000	15,326,497		Jun 04 03:48 PM
Cochran Hope F	Director	May 29 '26	Sale	350.00	1,000	350,000	27,010	Jun 02 04:51 PM
BV369 TRUST	Director	Jun 02 '26	Proposed Sale	398.07	44,050	17,534,803		Jun 02 04:12 PM
Dev Ittycheria	Director	Jun 02 '26	Proposed Sale	397.88	13,039	5,187,958		Jun 02 02:27 PM
Pech Cedric	Former employee	Jun 02 '26	Proposed Sale	396.00	51,002	20,196,792		Jun 02 02:19 PM
Thomas Bull	Officer	May 19 '26	Proposed Sale	334.08	3,131	1,046,000		May 27 05:49 PM
MERRIMAN DWIGHT A	Director	May 14 '26	Sale	297.99	10,000	2,979,914	993,316	May 18 05:02 PM
MERRIMAN DWIGHT A	Director	May 18 '26	Sale	314.98	6,000	1,889,884	470,896	May 18 05:02 PM
MERRIMAN DWIGHT A	Director	May 18 '26	Proposed Sale	314.85	6,000	1,889,093		May 18 11:36 AM
MERRIMAN DWIGHT A	Director	May 14 '26	Proposed Sale	297.86	10,000	2,978,599		May 14 01:28 PM
MERRIMAN DWIGHT A	Director	May 07 '26	Sale	290.06	2,000	580,120	1,003,316	May 11 05:15 PM
MERRIMAN DWIGHT A	Director	May 07 '26	Proposed Sale	289.93	2,000	579,851		May 07 02:45 PM
MERRIMAN DWIGHT A	Director	Apr 14 '26	Sale	236.89	8,000	1,895,110	1,005,316	Apr 16 05:12 PM
MERRIMAN DWIGHT A	Director	Apr 16 '26	Sale	252.33	4,000	1,009,305	476,896	Apr 16 05:12 PM
MERRIMAN DWIGHT A	Director	Apr 16 '26	Proposed Sale	252.11	4,000	1,008,433		Apr 16 11:33 AM
MERRIMAN DWIGHT A	Director	Apr 14 '26	Proposed Sale	236.76	8,000	1,894,059		Apr 14 11:32 AM
Cochran Hope F	Director	Apr 01 '26	Option Exercise	7.58	3,917	29,691	28,010	Apr 03 04:22 PM
Cochran Hope F	Director	Apr 01 '26	Sale	249.33	1,566	390,451	24,093	Apr 03 04:22 PM
HOPE COCHRAN	Director	Apr 01 '26	Proposed Sale	244.77	3,132	766,620		Apr 01 04:41 PM
MERRIMAN DWIGHT A	Director	Mar 13 '26	Sale	259.95	8,000	2,079,630	1,013,316	Mar 17 04:31 PM
MERRIMAN DWIGHT A	Director	Mar 16 '26	Sale	261.04	4,000	1,044,169	480,896	Mar 17 04:31 PM
MERRIMAN DWIGHT A	Director	Mar 16 '26	Proposed Sale	260.92	4,000	1,043,663		Mar 16 12:23 PM
MERRIMAN DWIGHT A	Director	Mar 13 '26	Proposed Sale	259.83	8,000	2,078,629		Mar 13 03:26 PM
MERRIMAN DWIGHT A	Director	Feb 13 '26	Sale	355.18	10,000	3,551,806	1,021,316	Feb 17 04:14 PM
MERRIMAN DWIGHT A	Director	Feb 12 '26	Sale	365.45	6,000	2,192,674	484,896	Feb 17 04:14 PM
MERRIMAN DWIGHT A	Director	Feb 17 '26	Sale	364.00	1,200	436,800	79,262	Feb 17 04:14 PM
MERRIMAN DWIGHT A	Director	Feb 17 '26	Proposed Sale	363.79	1,200	436,543		Feb 17 03:15 PM
MERRIMAN DWIGHT A	Director	Feb 13 '26	Proposed Sale	355.05	10,000	3,550,534		Feb 13 10:44 AM
MERRIMAN DWIGHT A	Director	Feb 12 '26	Proposed Sale	365.32	6,000	2,191,918		Feb 12 12:26 PM
Killalea Peter Thomas	Director	Nov 25 '25	Option Exercise	6.50	30,000	195,000	62,293	Feb 06 01:59 PM
MERRIMAN DWIGHT A	Director	Feb 02 '26	Sale	369.75	1,190	440,002	80,462	Feb 04 04:27 PM
MERRIMAN DWIGHT A	Director	Feb 02 '26	Proposed Sale	369.53	1,190	439,746		Feb 02 11:28 AM
MERRIMAN DWIGHT A	Director	Jan 14 '26	Sale	407.70	10,000	4,077,038	1,031,316	Jan 15 04:46 PM
MERRIMAN DWIGHT A	Director	Jan 13 '26	Sale	417.73	6,000	2,506,380	490,896	Jan 15 04:46 PM
MERRIMAN DWIGHT A	Director	Jan 15 '26	Sale	388.31	1,139	442,285	81,652	Jan 15 04:46 PM
MERRIMAN DWIGHT A	Director	Jan 15 '26	Proposed Sale	388.08	1,139	442,028		Jan 15 10:57 AM
MERRIMAN DWIGHT A	Director	Jan 14 '26	Proposed Sale	407.59	10,000	4,075,901		Jan 14 11:50 AM
MERRIMAN DWIGHT A	Director	Jan 13 '26	Proposed Sale	417.60	6,000	2,505,623		Jan 13 12:53 PM
MERRIMAN DWIGHT A	Director	Jan 02 '26	Sale	422.50	1,054	445,315	82,791	Jan 06 04:40 PM
MERRIMAN DWIGHT A	Director	Jan 02 '26	Proposed Sale	422.26	1,054	445,058		Jan 02 12:55 PM
Cochran Hope F	Director	Dec 17 '25	Option Exercise	7.58	3,917	29,691	27,225	Dec 18 05:01 PM
Cochran Hope F	Director	Dec 17 '25	Sale	421.85	1,566	660,617	25,659	Dec 18 05:01 PM
Cochran Hope F	Director	Dec 16 '25	Sale	410.03	1,000	410,030	23,308	Dec 18 05:01 PM
HOPE COCHRAN	Director	Dec 16 '25	Proposed Sale	416.00	2,566	1,067,456		Dec 16 04:26 PM
MERRIMAN DWIGHT A	Director	Dec 12 '25	Sale	417.83	10,000	4,178,300	1,041,316	Dec 16 04:21 PM
MERRIMAN DWIGHT A	Director	Dec 15 '25	Sale	419.11	6,000	2,514,641	496,896	Dec 16 04:21 PM
MERRIMAN DWIGHT A	Director	Dec 15 '25	Proposed Sale	419.10	6,000	2,514,595		Dec 15 12:21 PM
MERRIMAN DWIGHT A	Director	Dec 12 '25	Proposed Sale	417.70	10,000	4,177,021		Dec 12 11:35 AM
Bull Thomas	Chief Accounting Officer	Dec 08 '25	Sale	413.86	555	229,692	10,784	Dec 10 05:15 PM
BOTHA ROELOF	Director	Dec 05 '25	Sale	405.85	24,850	10,085,418	194,600	Dec 09 05:39 PM
THOMAS BULL	Officer	Dec 08 '25	Proposed Sale	413.86	555	229,692		Dec 08 04:30 PM
BV369 TRUST	Director	Dec 05 '25	Proposed Sale	405.85	24,850	10,085,417		Dec 05 05:06 PM
MERRIMAN DWIGHT A	Director	Dec 02 '25	Sale	410.00	4,000	1,640,000	1,051,316	Dec 04 05:58 PM
Hazard Charles M Jr	Director	Dec 01 '25	Sale	326.13	833	271,666	44,867	Dec 03 05:12 PM
Hazard Charles M Jr	Director	Dec 01 '25	Sale	326.13	166	54,138	13,995	Dec 03 05:12 PM
MERRIMAN DWIGHT A	Director	Dec 02 '25	Proposed Sale	409.94	4,000	1,639,743		Dec 02 01:20 PM
MERRIMAN DWIGHT A	Director	Nov 14 '25	Sale	338.52	10,000	3,385,221	1,055,316	Nov 18 04:55 PM
MERRIMAN DWIGHT A	Director	Nov 12 '25	Sale	372.46	6,000	2,234,762	502,896	Nov 14 04:31 PM
MERRIMAN DWIGHT A	Director	Nov 14 '25	Proposed Sale	338.40	10,000	3,384,013		Nov 14 11:05 AM
MERRIMAN DWIGHT A	Director	Nov 12 '25	Proposed Sale	372.33	6,000	2,233,993		Nov 12 02:24 PM
Hazard Charles M Jr	Director	Nov 03 '25	Sale	383.72	833	319,639	45,700	Nov 05 04:25 PM
Hazard Charles M Jr	Director	Nov 03 '25	Sale	383.72	166	63,698	14,161	Nov 05 04:25 PM
MERRIMAN DWIGHT A	Director	Oct 27 '25	Sale	345.00	4,000	1,380,000	1,065,316	Oct 29 04:17 PM
MERRIMAN DWIGHT A	Director	Oct 27 '25	Proposed Sale	344.94	4,000	1,379,743		Oct 27 12:22 PM
MERRIMAN DWIGHT A	Director	Oct 14 '25	Sale	311.62	10,000	3,116,233	1,069,316	Oct 16 04:30 PM
MERRIMAN DWIGHT A	Director	Oct 15 '25	Sale	315.99	4,000	1,263,960	510,896	Oct 16 04:30 PM
MERRIMAN DWIGHT A	Director	Oct 16 '25	Sale	322.00	2,000	644,000	508,896	Oct 16 04:30 PM
MERRIMAN DWIGHT A	Director	Oct 16 '25	Proposed Sale	321.87	2,000	643,743		Oct 16 11:22 AM
MERRIMAN DWIGHT A	Director	Oct 15 '25	Proposed Sale	315.86	4,000	1,263,437		Oct 15 04:08 PM
MERRIMAN DWIGHT A	Director	Oct 14 '25	Proposed Sale	311.49	10,000	3,114,943		Oct 14 12:26 PM
Hazard Charles M Jr	Director	Oct 01 '25	Sale	311.88	833	259,796	46,533	Oct 03 04:27 PM
Hazard Charles M Jr	Director	Oct 01 '25	Sale	311.88	166	51,772	14,327	Oct 03 04:27 PM
Killalea Peter Thomas	Director	Sep 23 '25	Option Exercise	6.50	20,000	130,000	52,293	Sep 25 04:38 PM
Killalea Peter Thomas	Director	Sep 23 '25	Sale	321.87	20,000	6,437,453	32,293	Sep 25 04:38 PM
PETER THOMAS KILLALEA	Director	Sep 23 '25	Proposed Sale	323.59	20,000	6,471,800		Sep 23 04:23 PM
MERRIMAN DWIGHT A	Director	Sep 19 '25	Sale	320.15	25,000	8,003,793	1,079,316	Sep 23 04:11 PM
MERRIMAN DWIGHT A	Director	Sep 19 '25	Sale	320.80	6,000	1,924,800	514,896	Sep 23 04:11 PM
Cochran Hope F	Director	Sep 17 '25	Option Exercise	7.58	2,937	22,262	25,482	Sep 19 04:43 PM
Cochran Hope F	Director	Sep 17 '25	Sale	327.93	1,174	384,990	24,308	Sep 19 04:43 PM
MERRIMAN DWIGHT A	Director	Sep 19 '25	Proposed Sale	320.21	31,000	9,926,573		Sep 19 02:54 PM

Open in Screener

NTRA

Natera Inc

312.72

Aug 11 • 3:59 PM ET -5.63 (-1.77%)

314.00

Aftermarket • 7:52 PM ET +1.28 (0.41%)

Healthcare Diagnostics & Research USA Large NASD

Peers: IQV LH ICLR IDXX A DHR TMO WAT MTD BIO

| Held by: VTI VB VBK VXF IBB IWP IWR IWF XBI JGRO

Index	-
Market Cap	45.08B
Enterprise Value	44.22B
Income	-192.35M
Sales	2.71B
Book/sh	12.68
Cash/sh	7.57
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6140
IPO	Jul 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	16.65
P/B	24.66
P/C	41.30
P/FCF	535.35
EV/EBITDA	-
EV/Sales	16.34
Quick Ratio	2.85
Current Ratio	3.00
Debt/Eq	0.13
LT Debt/Eq	0.08
Option/Short	Yes / Yes

EPS (ttm)	-1.37
EPS next Y	-0.18
EPS next Q	-0.23
EPS this Y	10.12%
EPS next Y	87.13%
EPS next 5Y	-
EPS past 3/5Y	35.09% 11.70%
Sales past 3/5Y	41.14% 42.61%
EPS Y/Y TTM	28.02%
Sales Y/Y TTM	37.82%
EPS Q/Q	36.85%
Sales Q/Q	37.71%
Earnings	Aug 06 AMC
EPS/Sales Surpr.	4.84% 13.84%

Insider Own	4.40%
Insider Trans	-9.20%
Inst Own	91.67%
Inst Trans	1.47%
ROA	-8.71%
ROE	-12.54%
ROIC	-9.79%
Gross Margin	64.74%
Oper. Margin	-10.56%
Profit Margin	-7.11%
SMA20	14.14%
SMA50	21.95%
SMA200	39.38%
Trades

Shs Outstand	143.61M
Shs Float	137.81M
Short Float	3.17%
Short Ratio	2.94
Short Interest	4.37M
52W High	326.03 -4.08%
52W Low	149.38 109.35%
Volatility	3.88% 4.10%
ATR (14)	14.22
RSI (14)	68.53
Beta	1.54
Rel Volume	0.64
Avg Volume	1.49M
Volume	953,404

Perf Week	13.64%
Perf Month	14.60%
Perf Quarter	57.04%
Perf Half Y	48.50%
Perf YTD	36.51%
Perf Year	99.13%
Perf 3Y	456.34%
Perf 5Y	204.91%
Perf 10Y	2750.68%
Recom	1.42
Target Price	322.81
Prev Close	318.35
Price	312.72
Change %	-1.77%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-26-26	Resumed	Bernstein	Outperform	$310
Jun-12-26	Resumed	RBC Capital Mkts	Outperform	$275
Jun-02-26	Resumed	Wolfe Research	Outperform	$260
Apr-14-26	Initiated	William Blair	Outperform
Jan-07-26	Initiated	Citigroup	Buy	$300
Dec-02-25	Resumed	Morgan Stanley	Overweight	$265
Oct-27-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$172
Sep-22-25	Resumed	Wells Fargo	Equal Weight	$175
Mar-13-25	Initiated	RBC Capital Mkts	Outperform	$251
Jan-23-25	Initiated	Barclays	Overweight	$200
Jun-03-24	Resumed	Jefferies	Buy	$142
Apr-08-24	Resumed	Craig Hallum	Buy	$117
Feb-20-24	Downgrade	Raymond James	Strong Buy → Outperform	$68 → $85
Dec-29-23	Reiterated	BTIG Research	Buy	$75 → $85
Dec-14-23	Initiated	Guggenheim	Buy	$70
Dec-13-23	Initiated	Wolfe Research	Outperform	$70
Nov-13-23	Upgrade	Raymond James	Outperform → Strong Buy	$68
Sep-28-23	Initiated	Bernstein	Mkt Perform	$48
Jul-05-23	Resumed	JP Morgan	Overweight	$85
May-05-23	Initiated	UBS	Buy	$76

Show Previous Ratings

Aug-07-26 01:55PM	These Two Biotech Stocks Hit Fresh 52-Week Highs Today NTRA Clocks Best Day In Nearly 20 Months (Stocktwits) +21.37%
10:42AM	SpaceX's influence ripples across markets: AlphaCheck (Yahoo Finance)
08:30AM	Natera, Inc. Q2 2026 Earnings Call Summary (Moby)
01:09AM	Natera Inc (NTRA) (Q2 2026) Earnings Call Highlights: Record Volumes and Raised Guidance Signal ... (GuruFocus.com)
Aug-06-26 05:30PM	Natera: Q2 Earnings Snapshot (Associated Press)
06:00AM	Loading…
Aug-05-26 06:00AM	Natera Submits Signatera to Japan's PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (Business Wire)
Aug-03-26 04:06PM	Buffett-Inspired ETF Owns Berkshire, Apple, Amex and Generates 15% Yield (Barrons.com)
Jul-30-26 08:00AM	Natera to Report its Second Quarter Results on August 6, 2026 (Business Wire) +6.24%
Jul-22-26 06:00AM	Signatera MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study (Business Wire)
Jul-20-26 12:06PM	Cathie Wood Dumps $39 Million Worth of AMD Stock (GuruFocus.com)
Jul-16-26 06:35PM	Finalized MolDx LCD Includes Expanded Coverage for Nateras Prospera Portfolio (Business Wire)
08:13AM	Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It's Entering the U.S. (TSXV: SEGN) (FinanceWire)
Jul-13-26 12:52PM	Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group (GuruFocus.com)
Jul-10-26 08:57AM	Cathie Wood Dumps AMD, Doubles Down on Meta Stock (GuruFocus.com)
Jul-09-26 06:00AM	Natera Announces IVDR Certification for Signatera Across Multiple Cancers (Business Wire)
06:00AM	Loading…
Jul-06-26 06:00AM	Signatera MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer (Business Wire)
Jul-02-26 06:41PM	CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology (Exec Edge)
Jul-01-26 06:02PM	When Multi-Cancer Blood Screens Could Finally Take Off (Barrons.com)
05:41PM	SkylineDxs Merlin CP-GEP Granted FDA Breakthrough Device Designation (Exec Edge)
Jun-29-26 06:00AM	Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer (Business Wire)
Jun-25-26 07:00AM	Natera and Eledon Announce Strategic Partnership for Prospera Monitoring in Planned Phase 3 Kidney Transplant Trial (Business Wire)
Jun-24-26 05:00AM	Signatera Receives Regulatory Approval in Japan for Colorectal Cancer (Business Wire) +10.74%
Jun-23-26 06:00AM	NCCN Recommends ctDNA-MRD Testing Using Signatera Technology in Landmark Bladder Cancer Guideline Update (Business Wire)
Jun-18-26 06:00AM	Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress (Business Wire)
Jun-05-26 10:40AM	Healthcare Stocks Can Benefit From AI, Too. But That Isn't the Reason to Buy Them. (Barrons.com)
09:36AM	Tesla upgraded, Lululemon downgraded: Wall Street's top analyst calls (The Fly)
Jun-04-26 08:00AM	Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer (Business Wire)
Jun-03-26 08:00AM	Natera Appoints Oncology Leaders Drs. Thomas Lynch and Eric Rubin to Board of Directors (Business Wire)
May-29-26 06:00AM	Natera Announces Collaboration with Diakonos Oncology for Signatera in Refractory Melanoma (Business Wire)
May-28-26 06:00AM	Natera Enrolls First Patients in SIGNAL-ER 101, a Prospective, Interventional Study Evaluating MRD-Guided Therapy in Breast Cancer (Business Wire) +5.33%
06:00AM	Loading…
May-26-26 06:00AM	Natera to Launch Enhanced Panorama NIPT, Powered by Novel SNP-Informed Deep Sequencing Technology (Business Wire)
May-21-26 05:05PM	Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology (Business Wire)
07:00AM	Natera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the World (Business Wire)
May-20-26 04:51PM	Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder (IPO-Edge.com)
07:00AM	EXPAND Trial of Nateras Fetal Focus Single-Gene NIPT Surpasses >2,000 Patients Enrolled (Business Wire)
May-15-26 05:18PM	Stanley Druckenmiller Exits State Street Financial Select Sector SPDR ETF, Impacting Portfolio ... (GuruFocus.com) -5.36%
12:45PM	Signatera CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) (Business Wire)
12:01AM	Nateras Stronghold in Cancer Recurrence Tests Prompts Woods Ark to Expand Stake (The Daily Upside)
May-14-26 05:30AM	The Cancer Test That Wall Street Is Betting On (The Wall Street Journal)
May-07-26 05:22PM	Natera: Q1 Earnings Snapshot (Associated Press) -11.64%
04:05PM	Natera Reports First Quarter 2026 Financial Results (Business Wire)
May-06-26 09:31AM	Why The Dip In TEM Stock Is A Buying Window (Trefis)
Apr-30-26 08:00AM	Natera to Report its First Quarter Results on May 7, 2026 (Business Wire) +5.86%
Apr-23-26 12:33PM	SkylineDx Presents Gene Expression Profiling for Skin Cancer Metastases (Exec Edge)
Apr-22-26 09:00AM	Prospera Evidence in Heart and Lung Transplantation Featured Across 17 Presentations at ISHLT (Business Wire)
Apr-13-26 08:00AM	Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma (Business Wire)
Apr-09-26 06:00AM	Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents (Business Wire)
Apr-07-26 06:00AM	20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera's Oncology Platform (Business Wire)
Mar-31-26 06:00AM	SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery (Business Wire) +7.04%
Mar-16-26 06:00AM	Two Publications Highlight Clinical Utility of Signatera in Anal and Rectal Cancers (Business Wire) +5.23%
Mar-12-26 08:00AM	Natera Announces Commercial Launch of Zenith Genomics for Rare Disease Diagnosis (Business Wire)
08:00AM	MyOme Debuts Zenith Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 (PR Newswire)
Mar-09-26 12:41AM	3 Healthcare Stocks to Target This Week (StockStory)
Mar-04-26 07:10AM	Signatera Oncology Test Drives Natera's (NTRA) Growth (Insider Monkey)
Mar-03-26 03:35PM	Natera (NTRA) Stock Trades Up, Here Is Why (StockStory)
Feb-27-26 12:40PM	Why Natera (NTRA) Shares Are Falling Today (StockStory)
10:05AM	Signatera MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation (Business Wire)
08:30AM	Personalis, Inc. Q4 2025 Earnings Call Summary (Moby)
12:07AM	Natera Q4 Earnings Call Highlights (MarketBeat)
12:05AM	Natera Inc (NTRA) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook ... (GuruFocus.com)
Feb-26-26 11:53PM	Natera, Inc. (NTRA) Announces Results From the SINERGY Trial (Insider Monkey)
06:45PM	Natera (NTRA) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:30PM	Natera (NTRA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:58PM	Natera: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Natera Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-24-26 10:28PM	Natera Earnings: What To Look For From NTRA (StockStory)
06:00AM	Successful Readout of Prospective Phase 2 SINERGY Trial Supports SignateraTM MRD-Guided Treatment in Head and Neck Cancer (Business Wire)
Feb-23-26 09:15AM	Unveiling Natera (NTRA) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Feb-18-26 07:00PM	Allogene Therapeutics Teases April ALPHA3 Data as cema-cel Targets MRD+ LBCL in Remission (MarketBeat)
08:10AM	Charles River Laboratories (CRL) Q4 Earnings and Revenues Surpass Estimates (Zacks)
Feb-17-26 04:01PM	Stanley Druckenmiller's Strategic Moves: A Closer Look at State Street Financial Select Sector ... (GuruFocus.com)
09:00AM	Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026 (Business Wire)
Feb-12-26 07:27AM	Surgery Partners (SGRY) Moves 7.7% Higher: Will This Strength Last? (Zacks)
Feb-11-26 09:56AM	EXEL Q4 Earnings and Revenues Beat, Colorectal Cancer Drug in Focus (Zacks)
Feb-10-26 07:40AM	CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates (Zacks)
Feb-06-26 06:00AM	Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes (Business Wire)
Feb-03-26 05:15PM	InnovAge Holding Corp. (INNV) Q2 Earnings and Revenues Surpass Estimates (Zacks) -9.69%
10:29AM	Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test (Zacks)
Feb-02-26 06:00AM	Natera Submits Signatera CDx PMA to FDA (Business Wire)
Jan-29-26 07:29AM	Natera, Inc. (NTRA) Reports Preliminary Q4 Revenue (Insider Monkey)
Jan-26-26 06:00AM	Prospera Featured in Landmark Interventional Study Advancing Lung Transplant Care (Business Wire)
Jan-25-26 11:38PM	2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds (StockStory)
Jan-23-26 10:53AM	Lack of Natera (NTRA) Exposure Weighs on Mid-Cap Fund Performance (Insider Monkey)
Jan-21-26 06:00AM	Natera Publishes Clinical Validation of Latitude Tissue-Free MRD Test in Colorectal Cancer (Business Wire)
Jan-20-26 06:00AM	Natera's Fetal Focus Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting (Business Wire)
Jan-13-26 10:45AM	NTRA & NVDA Partner to Improve AI Models for Precision Medicine (Zacks)
08:00AM	Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling (Business Wire)
Jan-12-26 10:00AM	Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA (Business Wire)
Jan-11-26 10:48PM	Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera Growth (Business Wire)
Jan-08-26 08:50AM	EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study (Zacks) -5.83%
Jan-07-26 02:11PM	Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera (CNBC TV)
09:41AM	Wayfair upgraded, Instacart initiated: Wall Street's top analyst calls (The Fly)
08:04AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: Applied Digital, BigBear.ai, Block, Deckers Outdoors, GitLab, Hershey, McDonalds, Moderna, and More (24/7 Wall St.)
08:00AM	Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer (Business Wire)
Jan-05-26 07:25PM	Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI (Business Wire)
07:00AM	Natera Launches 21-Gene Fetal Focus Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP Technology (Business Wire)
Dec-31-25 11:56AM	Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study (Insider Monkey)
Dec-30-25 02:16PM	Medical Stock Hovers Near Buy Point After 46% Gain (Investor's Business Daily)
Dec-26-25 03:40PM	Medical Stocks On The Move In Top Growth List As Health Sector Performance Brightens (Investor's Business Daily)
Dec-23-25 11:03PM	3 Reasons We're Fans of Natera (NTRA) (StockStory)

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Co-Founder & Executive ChairmanDr. Matthew Rabinowitz Ph.D.

CEO & DirectorMr. Steven Leonard Chapman

President & Chief Business OfficerMr. John Fesko

Chief Financial OfficerMr. Michael B. Brophy M.B.A.

President of Clinical DiagnosticsMr. Solomon Moshkevich M.B.A.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Aug 07 '26	Sale	320.90	2,000	641,800	2,000	Aug 07 09:35 PM
Sheena Jonathan	CO-FOUNDER	Aug 07 '26	Sale	315.66	9,150	2,888,325	236,464	Aug 07 09:35 PM
TINKERBELLE II TR U/A DTD 10/2	Officer	Aug 07 '26	Proposed Sale	320.90	2,000	641,800		Aug 07 05:42 PM
Sheena Jonathan	Director	Aug 07 '26	Proposed Sale	330.62	18,000	5,951,100		Aug 07 10:41 AM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Aug 04 '26	Sale	274.22	478	131,077	51,637	Aug 05 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Aug 03 '26	Sale	267.99	317	84,953	52,115	Aug 05 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Aug 03 '26	Sale	266.39	3,076	819,431	99,897	Aug 05 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Aug 03 '26	Sale	267.99	295	79,057	183,774	Aug 05 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Aug 03 '26	Sale	265.58	3,410	905,627	129,019	Aug 05 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Aug 03 '26	Sale	267.99	334	89,508	170,073	Aug 05 09:35 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Aug 03 '26	Sale	267.99	731	195,900	2,275,394	Aug 05 09:35 PM
Sheena Jonathan	CO-FOUNDER	Aug 03 '26	Sale	267.99	109	29,211	245,614	Aug 05 09:35 PM
MICHAEL BROPHY	Officer	Aug 04 '26	Proposed Sale	270.36	478	129,232		Aug 04 04:36 PM
JONATHAN SHEENA	OFFICER	Aug 03 '26	Proposed Sale	267.76	108	28,918		Aug 03 04:22 PM
MATTHEW RABINOWITZ	OFFICER	Aug 03 '26	Proposed Sale	267.76	722	193,323		Aug 03 04:22 PM
DANIEL RABINOWITZ	OFFICER	Aug 03 '26	Proposed Sale	267.76	330	88,361		Aug 03 04:22 PM
SOLOMON MOSHKEVICH	OFFICER	Aug 03 '26	Proposed Sale	267.76	405	108,443		Aug 03 04:21 PM
JOHN FESKO	OFFICER	Aug 03 '26	Proposed Sale	267.76	292	78,186		Aug 03 04:21 PM
STEVEN CHAPMAN	OFFICER	Aug 03 '26	Proposed Sale	267.76	1,167	312,476		Aug 03 04:21 PM
MICHAEL BROPHY	OFFICER	Aug 03 '26	Proposed Sale	267.76	313	83,809		Aug 03 04:20 PM
STEVEN L CHAPMAN	Officer	Aug 03 '26	Proposed Sale	265.40	1,894	502,668		Aug 03 04:18 PM
SOLOMON MOSHKEVICH	Officer	Aug 03 '26	Proposed Sale	265.25	3,000	795,751		Aug 03 04:09 PM
Sheena Jonathan	CO-FOUNDER	Jul 27 '26	Sale	260.49	288	75,021	245,914	Jul 29 09:35 PM
Sheena Jonathan	CO-FOUNDER	Jul 28 '26	Sale	254.07	191	48,527	245,723	Jul 29 09:35 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Jul 27 '26	Sale	260.49	1,718	447,523	2,276,125	Jul 29 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jul 28 '26	Sale	254.07	1,003	254,833	170,407	Jul 29 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jul 27 '26	Sale	260.49	884	230,274	171,410	Jul 29 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Jul 28 '26	Sale	254.07	1,204	305,901	132,429	Jul 29 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Jul 27 '26	Sale	260.49	1,010	263,096	133,633	Jul 29 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Jul 28 '26	Sale	254.07	931	236,540	184,069	Jul 29 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Jul 27 '26	Sale	260.49	782	203,704	185,000	Jul 29 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jul 28 '26	Sale	254.07	3,580	909,572	102,973	Jul 29 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jul 27 '26	Sale	260.49	2,190	570,475	106,553	Jul 29 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 28 '26	Sale	253.96	2,419	614,336	54,295	Jul 29 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 29 '26	Sale	249.38	1,863	464,595	52,432	Jul 29 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 27 '26	Sale	260.49	782	203,704	56,714	Jul 29 09:35 PM
MICHAEL BROPHY	Officer	Jul 29 '26	Proposed Sale	252.22	1,863	469,886		Jul 29 04:21 PM
MICHAEL BROPHY	Officer	Jul 28 '26	Proposed Sale	258.03	1,178	303,959		Jul 28 04:40 PM
JONATHAN SHEENA	DIRECTOR	Jul 28 '26	Proposed Sale	258.03	188	48,510		Jul 28 04:08 PM
DANIEL RABINOWITZ	OFFICER	Jul 28 '26	Proposed Sale	258.03	988	254,934		Jul 28 04:08 PM
SOLOMON MOSHKEVICH	OFFICER	Jul 28 '26	Proposed Sale	258.03	1,185	305,766		Jul 28 04:08 PM
JOH N FESKO	OFFICER	Jul 28 '26	Proposed Sale	258.03	917	236,614		Jul 28 04:08 PM
STEVEN CHAPMAN	OFFICER	Jul 28 '26	Proposed Sale	258.03	3,525	909,556		Jul 28 04:07 PM
MICHAEL BROPHY	OFFICER	Jul 28 '26	Proposed Sale	258.03	1,222	315,313		Jul 28 04:07 PM
JONATHAN SHEENA	DIRECTOR	Jul 27 '26	Proposed Sale	261.99	285	74,667		Jul 27 03:36 PM
MATTHEW RABINOWITZ	DIRECTOR	Jul 27 '26	Proposed Sale	261.99	1,697	444,597		Jul 27 03:36 PM
DANIEL RABINOWITZ	OFFICER	Jul 27 '26	Proposed Sale	261.99	873	228,717		Jul 27 03:36 PM
SOLOMON MOSHKEVICH	OFFICER	Jul 27 '26	Proposed Sale	261.99	998	261,466		Jul 27 03:36 PM
JOHN FESKO	OFFICER	Jul 27 '26	Proposed Sale	261.99	772	202,256		Jul 27 03:36 PM
STEVEN CHAPMAN	OFFICER	Jul 27 '26	Proposed Sale	261.99	2,163	566,684		Jul 27 03:35 PM
MICHAEL BROPHY	OFFICER	Jul 27 '26	Proposed Sale	261.99	772	202,256		Jul 27 03:35 PM
Sheena Jonathan	CO-FOUNDER	Jul 15 '26	Sale	273.88	1,500	410,825	18,032	Jul 17 09:05 PM
Chapman Rowan E	Director	Jul 15 '26	Sale	274.82	135	37,101	4,663	Jul 17 09:05 PM
Sheena Jonathan	CO-FOUNDER	Jul 13 '26	Sale	265.68	3,150	836,898	246,202	Jul 15 09:05 PM
ROWAN EMMA CHAPMAN	Director	Jul 15 '26	Proposed Sale	274.82	135	37,101		Jul 15 04:13 PM
Sheena Jonathan	Director	Jul 15 '26	Proposed Sale	275.22	1,500	412,830		Jul 15 10:10 AM
Sheena Jonathan	Director	Jul 13 '26	Proposed Sale	266.22	9,450	2,515,779		Jul 13 11:05 AM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Jul 06 '26	Sale	280.00	1,000	280,000	4,000	Jul 08 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jul 01 '26	Sale	272.29	16,800	4,574,431	172,294	Jul 06 09:05 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Jul 01 '26	Sale	272.90	3,000	818,710	134,643	Jul 06 09:05 PM
TINKERBELLE II TR U/A DTD 10/2	Officer	Jul 06 '26	Proposed Sale	280.00	1,000	280,000		Jul 06 04:56 PM
DANIEL RABINOWITZ	Officer	Jul 01 '26	Proposed Sale	271.45	16,800	4,560,360		Jul 01 04:15 PM
SOLOMON MOSHKEVICH	Officer	Jul 01 '26	Proposed Sale	272.90	3,000	818,710		Jul 01 04:13 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jun 24 '26	Sale	251.65	33,600	8,455,355	189,094	Jun 26 09:05 PM
ROSENMAN HERM	Director	Jun 24 '26	Sale	250.00	16,530	4,132,500	4,250	Jun 26 09:05 PM
DANIEL RABINOWITZ	Officer	Jun 24 '26	Proposed Sale	234.76	33,600	7,887,936		Jun 24 04:36 PM
HERMAN ROSENMAN	Director	Jun 24 '26	Proposed Sale	250.00	16,530	4,132,500		Jun 24 04:21 PM
Sheena Jonathan	CO-FOUNDER	Jun 17 '26	Sale	219.87	1,500	329,810	18,782	Jun 22 09:05 PM
Chapman Rowan E	Director	Jun 16 '26	Sale	216.78	2,964	642,536	3,124	Jun 17 09:05 PM
Sheena Jonathan	CO-FOUNDER	Jun 15 '26	Sale	211.14	3,150	665,087	249,352	Jun 17 09:05 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Jun 15 '26	Sale	214.91	50,000	10,745,662	2,277,843	Jun 16 09:35 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Jun 12 '26	Sale	214.03	50,000	10,701,645	2,327,843	Jun 16 09:35 PM
ROWAN EMMA CHAPMAN	Director	Jun 16 '26	Proposed Sale	216.78	2,964	642,536		Jun 16 04:02 PM
MATTHEW RABINOWITZ	Director	Jun 12 '26	Proposed Sale	219.23	100,000	21,923,000		Jun 12 04:42 PM
Marcus Gail Boxer	Director	Jun 05 '26	Option Exercise	22.83	11,000	251,130	17,183	Jun 09 09:05 PM
Marcus Gail Boxer	Director	Jun 05 '26	Sale	217.21	11,000	2,389,328	6,183	Jun 09 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jun 04 '26	Sale	221.03	41,124	9,089,776	108,743	Jun 05 09:05 PM
GAIL MARCUS	Director	Jun 05 '26	Proposed Sale	217.21	11,000	2,389,328		Jun 05 05:15 PM
STEVEN L CHAPMAN	Officer	Jun 04 '26	Proposed Sale	221.03	41,124	9,089,778		Jun 04 05:03 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Jun 01 '26	Sale	218.43	3,000	655,295	137,643	Jun 03 09:05 PM
BOTHA ROELOF	Director	Jun 01 '26	Sale	220.31	78,000	17,184,092	1,076,198	Jun 03 04:40 PM
BV369 TRUST	Affiliate	Jun 01 '26	Proposed Sale	220.31	78,000	17,184,094		Jun 01 04:12 PM
SOLOMON MOSHKEVICH	Officer	Jun 01 '26	Proposed Sale	218.43	3,000	655,295		Jun 01 04:05 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	May 26 '26	Sale	202.84	1,652	335,091	140,643	May 28 09:05 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	May 26 '26	Sale	202.84	1,438	291,684	185,782	May 28 09:05 PM
Sheena Jonathan	CO-FOUNDER	May 08 '26	Sale	208.60	3,150	657,104	252,502	May 15 09:05 PM
Sheena Jonathan	CO-FOUNDER	May 13 '26	Sale	201.56	1,500	302,347	19,532	May 15 09:05 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	May 05 '26	Sale	213.77	6,986	1,493,363	2,376,402	May 06 09:35 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	May 04 '26	Sale	206.16	722	148,848	2,382,440	May 06 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	May 04 '26	Sale	210.49	482	101,456	57,496	May 05 09:45 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	May 01 '26	Sale	206.16	313	64,528	57,978	May 05 09:45 PM
Sheena Jonathan	CO-FOUNDER	May 01 '26	Sale	206.16	107	22,059	255,652	May 05 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	May 01 '26	Sale	203.69	3,405	693,560	142,295	May 05 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	May 01 '26	Sale	206.16	291	59,993	187,220	May 05 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	May 01 '26	Sale	206.16	902	185,956	149,867	May 05 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	May 01 '26	Sale	206.16	330	68,033	222,694	May 05 09:35 PM
MICHAEL BROPHY	Officer	May 04 '26	Proposed Sale	207.28	482	99,909		May 04 04:52 PM
SOLOMON MOSHKEVICH	Officer	May 01 '26	Proposed Sale	203.35	3,000	610,065		May 01 04:08 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 29 '26	Sale	193.74	3,070	594,789	58,291	Apr 29 09:45 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 27 '26	Sale	204.14	1,993	406,856	61,361	Apr 29 09:45 PM

Open in Screener

LIFE

Ethos Technologies Inc

33.45

Aug 11 • 3:59 PM ET +1.02 (3.15%)

33.85

Aftermarket • 7:43 PM ET +0.40 (1.20%)

Financial Insurance Brokers USA Mid NASD

LIFE Ethos Technologies Inc daily Stock Chart

Peers: GSHD ARX BWIN NP AJG BRO AON WTW RYAN KNSL

| Held by: VTI VXF

Index	-
Market Cap	2.13B
Enterprise Value	1.98B
Income	-112.07M
Sales	586.53M
Book/sh	7.47
Cash/sh	2.64
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	614
IPO	Jan 29, 2026

P/E	-
Forward P/E	37.92
PEG	-
P/S	3.64
P/B	4.48
P/C	12.67
P/FCF	30.53
EV/EBITDA	-
EV/Sales	3.38
Quick Ratio	1.52
Current Ratio	1.52
Debt/Eq	0.04
LT Debt/Eq	0.02
Option/Short	No / Yes

EPS (ttm)	-1.78
EPS next Y	0.88
EPS next Q	0.09
EPS this Y	-276.37%
EPS next Y	141.00%
EPS next 5Y	-12.43%
EPS past 3/5Y	548.62% -
Sales past 3/5Y	55.77% -
EPS Y/Y TTM	-284.05%
Sales Y/Y TTM	83.24%
EPS Q/Q	4.25%
Sales Q/Q	113.35%
Earnings	Aug 03 AMC
EPS/Sales Surpr.	494.06% 61.58%

Insider Own	80.18%
Insider Trans	-1.82%
Inst Own	21.46%
Inst Trans	38.74%
ROA	-18.31%
ROE	-26.11%
ROIC	-21.91%
Gross Margin	97.01%
Oper. Margin	-17.67%
Profit Margin	-19.11%
SMA20	47.41%
SMA50	69.30%
SMA200	98.66%
Trades

Shs Outstand	31.55M
Shs Float	12.63M
Short Float	13.75%
Short Ratio	2.34
Short Interest	1.74M
52W High	32.86 1.80%
52W Low	9.45 253.97%
Volatility	12.37% 9.17%
ATR (14)	2.31
RSI (14)	86.26
Beta	-
Rel Volume	1.33
Avg Volume	743.10K
Volume	989,069

Perf Week	20.98%
Perf Month	73.23%
Perf Quarter	12.32%
Perf Half Y	172.62%
Perf YTD	76.05%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.22
Target Price	33.12
Prev Close	32.43
Price	33.45
Change %	3.15%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-23-26	Initiated	William Blair	Outperform
Feb-23-26	Initiated	Robert W. Baird	Outperform	$18
Feb-23-26	Initiated	JP Morgan	Overweight	$13
Feb-23-26	Initiated	Goldman	Buy	$33
Feb-23-26	Initiated	Deutsche Bank	Buy	$23
Feb-23-26	Initiated	Citizens	Mkt Outperform	$21
Feb-23-26	Initiated	Citigroup	Buy	$15
Feb-23-26	Initiated	BofA Securities	Buy	$15
Feb-23-26	Initiated	Barclays	Overweight	$20

Aug-04-26 01:07AM	Ethos Technologies Inc (LIFE) (Q2 2026) Earnings Call Highlights: Revenue Soars 113% to $190 ... (GuruFocus.com) +21.11%
Aug-03-26 04:05PM	Ethos Reports Second Quarter Fiscal Year 2026 Financial Results (GlobeNewswire) +11.80%
Jul-31-26 09:18AM	Earnings To Watch: Ethos Technologies Inc (LIFE) Reports Q2 2026 Result (GuruFocus.com)
Jul-21-26 09:07AM	Ethos and North American Expand Their Indexed Universal Life Product Offering to include Children (GlobeNewswire)
Jul-14-26 09:05AM	Ethos Partners with Amanda Kloots to Help Families Take Control of the One Thing They Can (GlobeNewswire)
04:35PM	Loading…
Jul-02-26 04:35PM	Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026 (GlobeNewswire)
May-26-26 03:08PM	Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now. (Barrons.com) +9.04%
May-21-26 09:07AM	Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential (GlobeNewswire)
May-15-26 04:30PM	Ethos to Present at Upcoming Investor Conferences (GlobeNewswire)
03:50PM	SoftBank Trims Tech Portfolio (GuruFocus.com)
May-13-26 04:35PM	Ethos Announces Early Lock-Up Release (GlobeNewswire) -8.06%
May-06-26 04:05PM	Ethos Reports First Quarter Fiscal Year 2026 Financial Results (GlobeNewswire) +9.83% +32.31%
May-05-26 09:07AM	Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users (GlobeNewswire) +8.00%
Apr-24-26 03:50PM	IPO Stock Of The Week: Life Insurer Ethos Technologies Eyes Buy Point After 78% Rally (Investor's Business Daily)
Apr-23-26 09:07AM	Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience (GlobeNewswire)
04:05PM	Loading…
Apr-02-26 04:05PM	Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026 (GlobeNewswire) +6.65%
Mar-24-26 04:05PM	Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families (GlobeNewswire) +5.85%
Mar-18-26 06:01PM	Evolve Announces March 2026 Distributions for UltraYield ETFs and Certain Evolve Funds (TMX Newsfile) -9.28% -7.41%
Mar-03-26 07:02AM	Citi Raises Ethos Technologies Inc. (LIFE) Price Target to $16 from $15 (Insider Monkey)
Feb-26-26 04:06PM	Ethos to Participate in The Citizens Technology Conference (GlobeNewswire)
Feb-23-26 09:32AM	Alphabet, Nvidia upgraded: Wall Street's top analyst calls (The Fly)
07:55AM	Here Are Mondays Top Wall Street Analyst Research Calls: Alphabet, Blackrock, Deere & Co., DocuSign, General Mills, Monday.com, Nvidia, Workday, and More (24/7 Wall St.)
Feb-04-26 02:00PM	The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts. (Barrons.com)
Feb-03-26 02:46PM	The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts. (Barrons.com) -8.42%
11:40AM	Opening Day: York Space Systems, Ethos make public debuts (TipRanks)

Ethos Technologies, Inc. provides life insurance services. Its policies cover debt, income, mortgages, and education. The company was founded by Ling Ke Wang and Peter Colis in July 2016 and is headquartered in San Francisco, CA.

Co-FounderMr. Peter George Colis

Co-FounderMr. Lingke Wang

Chief Technology OfficerMr. Vipul Sharma

Senior Vice President of FinanceMr. Kunal Mehta

Chief Financial OfficerMr. Christopher Michael Capozzi

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GV 2019 GP, L.L.C.	10% Owner	Jul 27 '26	Sale	19.46	196,931	3,832,848	0	Jul 29 07:28 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 28 '26	Sale	18.90	118,138	2,232,761	0	Jul 29 07:28 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 23 '26	Sale	19.06	63,297	1,206,270	0	Jul 27 06:21 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 24 '26	Sale	18.88	23,417	442,001	0	Jul 27 06:21 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 22 '26	Sale	19.23	49,582	953,467	0	Jul 23 04:47 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 21 '26	Sale	19.06	22,900	436,368	0	Jul 23 04:47 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 17 '26	Sale	18.68	20,534	383,614	0	Jul 21 05:11 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 20 '26	Sale	18.87	18,386	346,859	0	Jul 21 05:11 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 15 '26	Sale	19.66	74,492	1,464,685	0	Jul 17 08:12 PM
GV 2019 GP, L.L.C.	10% Owner	Jul 16 '26	Sale	18.73	19,595	367,008	0	Jul 17 08:12 PM
Wang Lingke	President	May 15 '26	Sale	22.11	46,349	1,024,561	764,836	May 19 08:34 PM
Colis Peter George	CEO and Secretary	May 15 '26	Sale	22.07	60,035	1,324,783	751,150	May 19 08:32 PM
Capozzi Christopher M.	Chief Financial Officer	May 15 '26	Sale	22.13	80,586	1,783,698	665,228	May 19 08:31 PM
Kucharski Brandt Walter	Chief Accounting Officer	May 15 '26	Sale	22.06	5,823	128,435	183,430	May 19 08:29 PM
GV 2019 GP, L.L.C.	10% Owner	May 15 '26	Sale	23.75	87,475	2,077,479	0	May 18 06:43 PM
GV 2019 GP, L.L.C.	10% Owner	May 14 '26	Sale	23.01	60,077	1,382,330	0	May 18 06:43 PM
Wang Lingke	Officer	May 15 '26	Proposed Sale	22.11	46,349	1,024,711		May 15 06:01 PM
Sharma Vipul	Former Affiliate	May 15 '26	Proposed Sale	22.09	44,778	989,016		May 15 06:00 PM
Lantz Erin N	Former Affiliate	May 15 '26	Proposed Sale	22.14	18,424	407,848		May 15 05:59 PM
Kucharski Brandt Walter	Officer	May 15 '26	Proposed Sale	22.06	5,823	128,440		May 15 05:59 PM
Colis Peter George	Officer	May 15 '26	Proposed Sale	22.07	60,035	1,324,947		May 15 05:58 PM
Capozzi Christopher M.	Officer	May 15 '26	Proposed Sale	22.14	80,586	1,783,842		May 15 05:57 PM
BOTHA ROELOF	Director	Jan 29 '26	Buy	19.00	260,525	4,949,975	260,525	Feb 02 06:36 PM
Sharma Vipul	Chief Technology Officer	Jan 30 '26	Sale	17.86	200,000	3,572,000	529,217	Jan 30 08:50 PM
WHEELER WILLIAM J	Director	Jan 30 '26	Buy	19.00	260,525	4,949,975	271,025	Jan 30 08:49 PM
Mullin Mark W.	Director	Jan 30 '26	Buy	19.00	5,263	99,997	17,451	Jan 30 08:48 PM
Kucharski Brandt Walter	Chief Accounting Officer	Jan 30 '26	Sale	17.86	12,428	221,964	132,484	Jan 30 08:46 PM
Lantz Erin N	Chief Revenue Officer	Jan 28 '26	Option Exercise	2.98	85,244	254,027	481,368	Jan 30 08:43 PM
Lantz Erin N	Chief Revenue Officer	Jan 30 '26	Sale	17.86	162,677	2,905,411	253,904	Jan 30 08:43 PM
GV 2017 GP, L.L.C.	10% Owner	Jan 30 '26	Sale	19.00	1,845,308	35,060,852	0	Jan 30 06:43 PM

MDB

MongoDB Inc

NTRA

Natera Inc

LIFE

Ethos Technologies Inc

Upgrade your Finviz experience